Attached files

file filename
EX-21.1 - EXHIBIT 21-1 - Enumeral Biomedical Holdings, Inc.s102860_ex21-1.htm
EX-32.2 - EXHIBIT 32-2 - Enumeral Biomedical Holdings, Inc.s102860_ex32-2.htm
EX-31.2 - EXHIBIT 31-2 - Enumeral Biomedical Holdings, Inc.s102860_ex31-2.htm
EX-32.1 - EXHIBIT 32-1 - Enumeral Biomedical Holdings, Inc.s102860_ex32-1.htm
EX-31.1 - EXHIBIT 31-1 - Enumeral Biomedical Holdings, Inc.s102860_ex31-1.htm
EX-10.35 - EXHIBIT 10.35 - Enumeral Biomedical Holdings, Inc.s102860_ex10-35.htm
EX-10.31 - EXHIBIT 10.31 - Enumeral Biomedical Holdings, Inc.s102860_ex10-31.htm
EX-10.37 - EXHIBIT 10-37 - Enumeral Biomedical Holdings, Inc.s102860_ex10-37.htm
EX-10.38 - EXHIBIT 10-38 - Enumeral Biomedical Holdings, Inc.s102860_ex10-38.htm
10-K - FORM 10-K - Enumeral Biomedical Holdings, Inc.s102860_10k.htm

   

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-203351) of Enumeral Biomedical Holdings, Inc. and Subsidiaries of our report dated March 30, 2016, which contains an explanatory paragraph regarding the Company’s ability to continue as a going concern, with respect to the consolidated financial statements which appear in this Annual Report on Form 10-K.

 

/s/ FRIEDMAN LLP

New York, New York

March 30, 2016